{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:12:46Z","timestamp":1775265166423,"version":"3.50.1"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1001\/jamainternmed.2018.4757","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T19:14:21Z","timestamp":1541531661000},"page":"1690","source":"Crossref","is-referenced-by-count":1,"title":["Use of Renin Angiotensin System Blockers After Acute Kidney Injury"],"prefix":"10.1001","volume":"178","author":[{"given":"Robert J.","family":"Alpern","sequence":"first","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo J.","family":"Peixoto","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"1","key":"iic180046r1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","article-title":"KDIGO clinical practice guideline for acute kidney injury.","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"iic180046r2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1053\/j.ackd.2016.01.014","article-title":"Delayed consequences of acute kidney injury.","volume":"23","author":"Parr","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"iic180046r3","doi-asserted-by":"publisher","first-page":"j4","DOI":"10.1136\/bmj.j4","article-title":"Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials.","volume":"356","author":"Bangalore","year":"2017","journal-title":"BMJ"},{"issue":"14","key":"iic180046r4","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.jacc.2016.01.050","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in myocardial infarction patients with renal dysfunction.","volume":"67","author":"Evans","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"iic180046r5","article-title":"Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury [published online May 15, 2018].","author":"Gayat","journal-title":"Intensive Care Med"},{"key":"iic180046r6","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with outcomes after acute kidney injury.","author":"Brar","journal-title":"JAMA Intern Med"},{"issue":"1","key":"iic180046r7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/phar.2018.38.issue-1","article-title":"Incidence of and risk factors for severe adverse events in elderly patients taking angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers after an acute myocardial infarction.","volume":"38","author":"Fang","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"1","key":"iic180046r8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijcard.2011.01.081","article-title":"Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction: a meta analysis of 7 prospective clinical studies.","volume":"155","author":"Fu","year":"2012","journal-title":"Int J Cardiol"},{"issue":"8","key":"iic180046r9","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/ndt\/16.8.1592","article-title":"Haemodynamic effects of valsartan in acute renal ischaemia\/reperfusion injury.","volume":"16","author":"Lopau","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"iic180046r10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ndt\/gfv346","article-title":"Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.","volume":"31","author":"Bhandari","year":"2016","journal-title":"Nephrol Dial Transplant"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2707951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:07:24Z","timestamp":1775261244000},"score":1,"resource":{"primary":{"URL":"http:\/\/archinte.jamanetwork.com\/article.aspx?doi=10.1001\/jamainternmed.2018.4757"}},"subtitle":["Balancing Tradeoffs"],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2018.4757","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}